<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57137">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02062333</url>
  </required_header>
  <id_info>
    <org_study_id>2013/425</org_study_id>
    <nct_id>NCT02062333</nct_id>
  </id_info>
  <brief_title>The Effects of the Drugs Used in Hypotensive Anaesthesia on Cochlea</brief_title>
  <official_title>The Effects of the Drugs Used in Hypotensive Anaesthesia on Cochlea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to find  the Effects of Anesthetics Used in Hypotensive Anesthesia
      on Stapes Reflex and Distortion Product Auto Acoustic Emission.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was aimed at evaluating the effects of dexmedetomidine and esmolol on stapes
      reflex and  distortion product auto acoustic emission. the stapes reflex and  auto acoustic
      emission are of considerable diagnostic significances in otolaryngology   this are objective
      methods for the assessment of auditory function.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>distortion product auto acoustic emission</measure>
    <time_frame>postoperative 1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>distortion product measurements will be performed in 1001, 1501, 2002, 3003, 4004, 6006, 7996 Hz frequencies and change from baseline in distortion product measurements at  postoperative 1 day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stapes reflex</measure>
    <time_frame>postoperative 1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>stapes muscle reflex measurements will be performed by electrical impedance. data will be taken as graphics. ıf there is an amplitude on graphic the data will be  assumed  as stapes reflex positive.Change from Baseline in stapes muscle reflex at postoperative 1 day</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia; Adverse Effect</condition>
  <condition>Reflex, Abnormal</condition>
  <condition>Tinnitus, Spontaneous Oto-Acoustic Emission</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0,4-0,8 µg./kg./h dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>esmolol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>100- 300 µg./kg./min esmolol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>esmolol</intervention_name>
    <arm_group_label>esmolol</arm_group_label>
    <other_name>breviblock</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 age

          -  American Society of Anaesthesiologists physical status classification (ASA)1-2

          -  tympanoplasty surgery

          -  patients with normal stapes reflexes

        Exclusion Criteria:

          -  hypertension

          -  drug allergy

          -  cardiac problems

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunhan Gokahmetoglu, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gunhan Gokahmetoglu, M.D</last_name>
    <phone>+905336314488</phone>
    <email>gunhangok@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Recep Aksu, associate prof.</last_name>
    <phone>+903522076666</phone>
    <phone_ext>24035</phone_ext>
    <email>raksu@erciyes.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kayseri Education and Research Hospital</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>gunhan gokahmetoglu, M.D</last_name>
      <phone>+905336314488</phone>
      <email>gunhangok@gmail.com</email>
    </contact>
    <investigator>
      <last_name>recep aksu, associate prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 12, 2014</lastchanged_date>
  <firstreceived_date>February 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>Recep Aksu</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>esmolol</keyword>
  <keyword>stapes reflex</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Reflex, Abnormal</mesh_term>
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Antihypertensive Agents</mesh_term>
    <mesh_term>Esmolol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
